EQ – equillium, inc. (US:NASDAQ)

News

Equillium (NASDAQ:EQ) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Equillium to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Equillium to Participate in Upcoming Investor Conferences
Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases Transcript [Seeking Alpha]
Equillium to Participate in Upcoming Investor Conferences
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com